H19 and neoplasm: Although the aforementioned models show promising potential for clinical use of H19 expression as a biomarker in either tumor tissue or plasma samples for disease detection and prognosis prediction in GCs, Further research is required to fully establish H19 as a dependable and consistent biomarker.